The Benefits of Using Genetic Information to Design Prevention Trials-Reference-Cited by-同舟云学术

The Benefits of Using Genetic Information to Design Prevention Trials

Published:2013-04 Issue:4 Volume:92 Page:547-557
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Hu Youna,Li Li,Ehm Margaret G.,Bing Nan,Song Kijoung,Nelson Matthew R.,Talmud Philippa J.,Hingorani Aroon D.,Kumari Meena,Kivimäki Mika,Xu Chun-Fang,Waterworth Dawn M.,Whittaker John C.,Abecasis Gonçalo R.,Spino Cathie,Kang Hyun Min

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference35 articles.

1. Key factors in the rising cost of new drug discovery and development;Dickson;Nat. Rev. Drug Discov.,2004

2. Disease-modifying therapies for Alzheimer disease: challenges to early intervention;Cummings;Neurology,2007

3. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program;Florez;N. Engl. J. Med.,2006

4. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein;Ridker;N. Engl. J. Med.,2008

5. The use of genomics in clinical trial design;Simon;Clin. Cancer Res.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease;Dialogues in Clinical Neuroscience;2019-06-10

2. Genotype-Based Recall Studies in Complex Cardiometabolic Traits;Circulation: Genomic and Precision Medicine;2018-08

3. A Blood Test for Alzheimer’s Disease: Progress, Challenges, and Recommendations;Journal of Alzheimer's Disease;2018-06-12

4. Key Aspects of Modern, Quantitative Drug Development;Statistics in Biosciences;2018-05-10

5. Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference;Nature Communications;2018-02-19